1616622-82-2

Upstream product

• 1616622-81-1 C₁₈H₁₈N₂O₃ 
• 98-59-9 p-toluenesulfonyl chloride 
• 1616622-80-0 8-(5-(2-tert-butyldimethylsilyloxyethyloxy)pyridin-3-yl)-1,2,5,6-tetrahydro-4H-pyrrolo[3,2,1-ij]quinolin-4-one 
• 496-15-1 1-indoline 
• 64140-62-1 N-(β-chloropropionyl)-indoline 
• 57369-32-1 pyroquilone 
• 57368-91-9 8-bromo-1,2,5,6-tetrahydro-4H-pyrrolo[3,2,1-ij]quinolin-4-one 
• 1194459-23-8 8-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-1,2,5,6-tetrahydro-4H-pyrrolo[3,2,1-ij]quinolin-4-one 
• 1616622-76-4 3-bromo-5-(2-((tert-butyldimethylsilyl)oxy)ethoxy)pyridine 

Relevant academic research and scientific papers

RADIOACTIVE QUINOLINONE DERIVATIVE AND PHARMACEUTICAL DRUG COMPRISING THE SAME

It is intended to provide a radioactive compound that has higher selectivity for CYP11B2 than that for CYP11B1, exhibits highly selective accumulation in the adrenal gland compared with blood and organs adjacent to the adrenal gland, and permits commercial supply. The present invention provides a radioactive quinolinone derivative represented by the predetermined general formula or a salt thereof.